Report Detail

Medical Devices & Consumables Global Surgical Bioadhesive Market Research Report 2022

  • RnM4453090
  • |
  • 13 June, 2022
  • |
  • Global
  • |
  • 89 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Industry Insights
Due to the COVID-19 pandemic, the global Surgical Bioadhesive market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Surgical Bioadhesive market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Surgical Bioadhesive landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Fibrin accounting for % of the Surgical Bioadhesive global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Surgical Bioadhesive include Baxter, Johnson & Johnson, Shanghai RAAS Blood Products, Hualan Biological Engineering, Bioseal Biotech, CSL Behring, Harbin Hanbang Medical Science and Technology, Jiangyin USUN Pharmaceutical and Kollodis BioSciences. etc. In terms of revenue, the global 3 largest players have a % market share of Surgical Bioadhesive in 2021.

This report focuses on Surgical Bioadhesive volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Surgical Bioadhesive market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Surgical Bioadhesive market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Fibrin

Mussel Adhesive Protein

Others

Segment by Application

Hospital

Clinic

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Baxter

Johnson & Johnson

Shanghai RAAS Blood Products

Hualan Biological Engineering

Bioseal Biotech

CSL Behring

Harbin Hanbang Medical Science and Technology

Jiangyin USUN Pharmaceutical

Kollodis BioSciences

Frequently Asked Questions

Which product segment grabbed the largest share in the Surgical Bioadhesive market?

How is the competitive scenario of the Surgical Bioadhesive market?

Which are the key factors aiding the Surgical Bioadhesive market growth?

Which are the prominent players in the Surgical Bioadhesive market?

Which region holds the maximum share in the Surgical Bioadhesive market?

What will be the CAGR of the Surgical Bioadhesive market during the forecast period?

Which application segment emerged as the leading segment in the Surgical Bioadhesive market?

What key trends are likely to emerge in the Surgical Bioadhesive market in the coming years?

What will be the Surgical Bioadhesive market size by 2028?

Which company held the largest share in the Surgical Bioadhesive market?


1 Surgical Bioadhesive Market Overview

  • 1.1 Product Overview and Scope of Surgical Bioadhesive
  • 1.2 Surgical Bioadhesive Segment by Type
  • 1.2.1 Global Surgical Bioadhesive Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 Fibrin
  • 1.2.3 Mussel Adhesive Protein
  • 1.2.4 Others
  • 1.3 Surgical Bioadhesive Segment by Application
  • 1.3.1 Global Surgical Bioadhesive Sales Comparison by Application: (2022-2028)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
  • 1.4 Global Surgical Bioadhesive Market Size Estimates and Forecasts
  • 1.4.1 Global Surgical Bioadhesive Revenue 2017-2028
  • 1.4.2 Global Surgical Bioadhesive Sales 2017-2028
  • 1.4.3 Surgical Bioadhesive Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Surgical Bioadhesive Market Competition by Manufacturers

    • 2.1 Global Surgical Bioadhesive Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Surgical Bioadhesive Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Surgical Bioadhesive Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Surgical Bioadhesive Manufacturing Sites, Area Served, Product Type
    • 2.5 Surgical Bioadhesive Market Competitive Situation and Trends
    • 2.5.1 Surgical Bioadhesive Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Surgical Bioadhesive Players Market Share by Revenue
  • 2.5.3 Global Surgical Bioadhesive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Surgical Bioadhesive Retrospective Market Scenario by Region

    • 3.1 Global Surgical Bioadhesive Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Surgical Bioadhesive Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Surgical Bioadhesive Market Facts & Figures by Country
    • 3.3.1 North America Surgical Bioadhesive Sales by Country
  • 3.3.2 North America Surgical Bioadhesive Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Surgical Bioadhesive Market Facts & Figures by Country
  • 3.4.1 Europe Surgical Bioadhesive Sales by Country
  • 3.4.2 Europe Surgical Bioadhesive Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Surgical Bioadhesive Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Surgical Bioadhesive Sales by Region
  • 3.5.2 Asia Pacific Surgical Bioadhesive Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Surgical Bioadhesive Market Facts & Figures by Country
  • 3.6.1 Latin America Surgical Bioadhesive Sales by Country
  • 3.6.2 Latin America Surgical Bioadhesive Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.7 Middle East and Africa Surgical Bioadhesive Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Surgical Bioadhesive Sales by Country
  • 3.7.2 Middle East and Africa Surgical Bioadhesive Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Surgical Bioadhesive Historic Market Analysis by Type

    • 4.1 Global Surgical Bioadhesive Sales Market Share by Type (2017-2022)
    • 4.2 Global Surgical Bioadhesive Revenue Market Share by Type (2017-2022)
    • 4.3 Global Surgical Bioadhesive Price by Type (2017-2022)

    5 Global Surgical Bioadhesive Historic Market Analysis by Application

    • 5.1 Global Surgical Bioadhesive Sales Market Share by Application (2017-2022)
    • 5.2 Global Surgical Bioadhesive Revenue Market Share by Application (2017-2022)
    • 5.3 Global Surgical Bioadhesive Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Baxter
    • 6.1.1 Baxter Corporation Information
  • 6.1.2 Baxter Description and Business Overview
  • 6.1.3 Baxter Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Baxter Surgical Bioadhesive Product Portfolio
  • 6.1.5 Baxter Recent Developments/Updates
  • 6.2 Johnson & Johnson
  • 6.2.1 Johnson & Johnson Corporation Information
  • 6.2.2 Johnson & Johnson Description and Business Overview
  • 6.2.3 Johnson & Johnson Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Johnson & Johnson Surgical Bioadhesive Product Portfolio
  • 6.2.5 Johnson & Johnson Recent Developments/Updates
  • 6.3 Shanghai RAAS Blood Products
  • 6.3.1 Shanghai RAAS Blood Products Corporation Information
  • 6.3.2 Shanghai RAAS Blood Products Description and Business Overview
  • 6.3.3 Shanghai RAAS Blood Products Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Shanghai RAAS Blood Products Surgical Bioadhesive Product Portfolio
  • 6.3.5 Shanghai RAAS Blood Products Recent Developments/Updates
  • 6.4 Hualan Biological Engineering
  • 6.4.1 Hualan Biological Engineering Corporation Information
  • 6.4.2 Hualan Biological Engineering Description and Business Overview
  • 6.4.3 Hualan Biological Engineering Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Hualan Biological Engineering Surgical Bioadhesive Product Portfolio
  • 6.4.5 Hualan Biological Engineering Recent Developments/Updates
  • 6.5 Bioseal Biotech
  • 6.5.1 Bioseal Biotech Corporation Information
  • 6.5.2 Bioseal Biotech Description and Business Overview
  • 6.5.3 Bioseal Biotech Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 Bioseal Biotech Surgical Bioadhesive Product Portfolio
  • 6.5.5 Bioseal Biotech Recent Developments/Updates
  • 6.6 CSL Behring
  • 6.6.1 CSL Behring Corporation Information
  • 6.6.2 CSL Behring Description and Business Overview
  • 6.6.3 CSL Behring Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 CSL Behring Surgical Bioadhesive Product Portfolio
  • 6.6.5 CSL Behring Recent Developments/Updates
  • 6.7 Harbin Hanbang Medical Science and Technology
  • 6.6.1 Harbin Hanbang Medical Science and Technology Corporation Information
  • 6.6.2 Harbin Hanbang Medical Science and Technology Description and Business Overview
  • 6.6.3 Harbin Hanbang Medical Science and Technology Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Harbin Hanbang Medical Science and Technology Surgical Bioadhesive Product Portfolio
  • 6.7.5 Harbin Hanbang Medical Science and Technology Recent Developments/Updates
  • 6.8 Jiangyin USUN Pharmaceutical
  • 6.8.1 Jiangyin USUN Pharmaceutical Corporation Information
  • 6.8.2 Jiangyin USUN Pharmaceutical Description and Business Overview
  • 6.8.3 Jiangyin USUN Pharmaceutical Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Jiangyin USUN Pharmaceutical Surgical Bioadhesive Product Portfolio
  • 6.8.5 Jiangyin USUN Pharmaceutical Recent Developments/Updates
  • 6.9 Kollodis BioSciences
  • 6.9.1 Kollodis BioSciences Corporation Information
  • 6.9.2 Kollodis BioSciences Description and Business Overview
  • 6.9.3 Kollodis BioSciences Surgical Bioadhesive Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 Kollodis BioSciences Surgical Bioadhesive Product Portfolio
  • 6.9.5 Kollodis BioSciences Recent Developments/Updates
  • 7 Surgical Bioadhesive Manufacturing Cost Analysis

    • 7.1 Surgical Bioadhesive Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Surgical Bioadhesive
  • 7.4 Surgical Bioadhesive Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Surgical Bioadhesive Distributors List
    • 8.3 Surgical Bioadhesive Customers

    9 Surgical Bioadhesive Market Dynamics

    • 9.1 Surgical Bioadhesive Industry Trends
    • 9.2 Surgical Bioadhesive Market Drivers
    • 9.3 Surgical Bioadhesive Market Challenges
    • 9.4 Surgical Bioadhesive Market Restraints

    10 Global Market Forecast

    • 10.1 Surgical Bioadhesive Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Surgical Bioadhesive by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Surgical Bioadhesive by Type (2023-2028)
  • 10.2 Surgical Bioadhesive Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Surgical Bioadhesive by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Surgical Bioadhesive by Application (2023-2028)
  • 10.3 Surgical Bioadhesive Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Surgical Bioadhesive by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Surgical Bioadhesive by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on Surgical Bioadhesive. Industry analysis & Market Report on Surgical Bioadhesive is a syndicated market report, published as Global Surgical Bioadhesive Market Research Report 2022. It is complete Research Study and Industry Analysis of Surgical Bioadhesive market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,311.30
      4,622.60
      2,694.10
      5,388.20
      444,367.00
      888,734.00
      241,976.00
      483,952.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report